A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors
Clinical trial NCT02605083 · TERMINATED
Trial details
- NCT number
- NCT02605083
- Sponsor
- Effector Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2019-01-11
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.